CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Monitoring with near-infrared spectroscopyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03738644
NCT03738644N/ACompleted
CompareCT.gov

Near-infrared Spectroscopy in Endovascular Treatment (Danish: Nær-infrarød Spektroskopi Ved endovaskulær Trombektomi)

Helle Klingenberg Iversen·observational·Posted Nov 13, 2018·Updated Mar 18, 2021

In Brief

An observational study evaluating Monitoring with near-infrared spectroscopy for Ischemic Stroke. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the hemodynamics of stroke patients with near-infrared spectroscopy before, during and after endovascular treatment and their relations to disabilities and mortality 3 months after treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 13, 2018
Enrollment StartNov 20, 2018
Primary CompletionFeb 15, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.6 years ago

Interventions

Monitoring with near-infrared spectroscopyother

No interventions are used. Stroke patients are examined with near-infrared spectroscopy (NIRS). NIRS examinations are done with Octamon system (Artinis Medical Systems, Elst, The Netherlands) consisting of 8 transmitters emitting infrared light of 760 and 850 nm and 2 receivers measuring oxygenated and deoxygenated hemoglobin in the frontal cortex. Examination protocol can be found in detailed description.